Wake Forest University Health Sciences
Dr. Colleen A. Hanlon is a professor at Wake Forest University Health Sciences and a member of the Executive Committee of the Wake Forest Center for Addiction Research. There she leads a multidisciplinary clinical research program currently focused on refining and optimizing transcranial magnetic stimulation as a therapeutic tool for drug and alcohol use disorders. She is the senior author on the first “Consensus Paper” published by a group of over 70 scientists from over 10 countries outlining the path forward for Non-Invasive Therapeutic Development for Addiction. She received a Ph.D. in Neurobiology from Duke University in 2005. In the subsequent 17 years, she has received over $12 million in NIH support to develop neural-circuit based therapeutics for drug and alcohol use disorders. She was honored with the Early Career Investigator award from the National Institute of Drug Abuse. She has published over 70 articles, authored 6 book chapters, given over 100 invited talks, has directed the Advanced TMS Training Course sponsored by the National Center for Neuromodulation for Rehabilitation, and has been a mentor to over 60 medical, graduate, post-graduate, and undergraduate trainees on a national and international scale – many of whom are now leading their own research laboratories, or serving the community as clinical TMS providers and/or in the substance abuse treatment field.
Most importantly, she loves science and getting others excited about medical discovery – “it is a process and a privilege.” She is finds a unique joy scientific outreach and nurturing the creative ideas among her students and her colleagues. She created an annual addiction outreach event at the College of Problems on Drug Dependence (CPDD) meeting (2015-2019), served on the Liaison Committee (2016-2019) and the Education and Training Committee (2019-present) for the American College of Neuropsychopharmacology, Grassroots Advocacy Team for the Society for Neuroscience (2017-2019), Chair of the Education Outreach and Public Policy Committee for CPDD (2017-2019), ad hoc participation in over 25 NIH study sections, and serving as a standing member of NIH NPAS study section (effective 10/2018).
Friday, August 19, 2022
3:30 PM – 4:30 PM